Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients.

Hayashi, Takuma; Konishi, Ikuo

Hayashi, Takuma; Konishi, Ikuo.

Hayashi T; National Hospital Organization, Kyoto Medical Center, Kyoto, Japan. yoyoyo224@hotmail.com.
Konishi I; START-program, Japan Science and Technology Agency (JST), Tokyo, Japan. yoyoyo224@hotmail.com.

Br J Cancer ; 126(4): 521-522, 2022 03.

Article in English | MEDLINE | ID: covidwho-1593995

Subject(s)

COVID-19/complications; Neoplasms/therapy; COVID-19/virology; Humans; Neoplasms/complications; Neoplasms/metabolism; Phosphatidylinositol 3-Kinases/metabolism; SARS-CoV-2/isolation & purification; TOR Serine-Threonine Kinases/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Long Covid Limits: Humans Language: English Journal: Br J Cancer Year: 2022 Document Type: Article Affiliation country: S41416-021-01685-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google